Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLAPARIB vs OLMETEC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OLAPARIB vs OLMETEC: Safety Overview

Metric OLAPARIB OLMETEC
Total FAERS Reports 18,274 129
Deaths Reported 5,496 11
Death Rate 30.1% 8.5%
Hospitalizations 3,471 80
Average Patient Age 62.3 yrs 70.3 yrs
% Female Patients 79.9% N/A
FDA Approval Date Aug 17, 2017 N/A
Manufacturer AstraZeneca Pharmaceuticals LP N/A
Route ORAL N/A
Marketing Status Discontinued N/A